Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices.
Gilead Sciences Inc agreed to buy Kite Pharma Inc in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with an emerging and expensive class of cancer immunotherapies that are expected to generate billions of dollars in revenue.
Japan's Mitsubishi Tanabe Pharma Corp (4508.T) has agreed to buy Israeli drug maker Neuroderm (NDRM.O) for $1.1 billion in cash as part of a strategy to grow its business in the United States.
Advanced Gene & Cell Technologies (AGCT), a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice of genome editing to treat HIV. AGCT plans to use the investment, which totals 44 million rubles ($738,000), to draw up a raft of preclinical data to carry out pilot phase one and two clinical research.
With $65 million in new funding, DARPA seeks to develop neural implants that make it possible for the human brain to speak directly to computer interfaces. As part of its Neural Engineering System Design (NESD) program, the agency will fund five academic research groups and one small San Jose-based company to further its goals.